JPH0316946B2 - - Google Patents
Info
- Publication number
- JPH0316946B2 JPH0316946B2 JP9754483A JP9754483A JPH0316946B2 JP H0316946 B2 JPH0316946 B2 JP H0316946B2 JP 9754483 A JP9754483 A JP 9754483A JP 9754483 A JP9754483 A JP 9754483A JP H0316946 B2 JPH0316946 B2 JP H0316946B2
- Authority
- JP
- Japan
- Prior art keywords
- serine
- threo
- carbobenzoxy
- racemic
- dihydroxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 22
- 239000002841 Lewis acid Substances 0.000 claims description 11
- -1 carbobenzoxy-3-(3,4-dihydroxyphenyl)serine Chemical compound 0.000 claims description 11
- 150000007517 lewis acids Chemical class 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000002904 solvent Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 4
- 238000010531 catalytic reduction reaction Methods 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- ZDYUUBIMAGBMPY-UHFFFAOYSA-N oxalic acid;hydrate Chemical compound O.OC(=O)C(O)=O ZDYUUBIMAGBMPY-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000003935 benzaldehydes Chemical class 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- WQAQPCDUOCURKW-UHFFFAOYSA-N butanethiol Chemical compound CCCCS WQAQPCDUOCURKW-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003354 serine derivatives Chemical class 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- WTAKTSZELSYVQL-LURJTMIESA-N (2s)-2-(3,4-dihydroxyanilino)-3-hydroxypropanoic acid Chemical compound OC[C@@H](C(O)=O)NC1=CC=C(O)C(O)=C1 WTAKTSZELSYVQL-LURJTMIESA-N 0.000 description 1
- QCCQWLWXLUTSAK-LBPRGKRZSA-N (2s)-2-amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid Chemical compound COC1=CC=C(C[C@](C)(N)C(O)=O)C=C1OC QCCQWLWXLUTSAK-LBPRGKRZSA-N 0.000 description 1
- STMOVTSFWYRCOB-DKWTVANSSA-N (2s)-2-amino-3-hydroxypropanoic acid;hydrochloride Chemical compound Cl.OC[C@H](N)C(O)=O STMOVTSFWYRCOB-DKWTVANSSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- XHBLRJRZRFZSGW-UHFFFAOYSA-N 2-azaniumyl-3-(1,3-benzodioxol-5-yl)propanoate Chemical compound OC(=O)C(N)CC1=CC=C2OCOC2=C1 XHBLRJRZRFZSGW-UHFFFAOYSA-N 0.000 description 1
- MBMKGIRTTXAGCM-YFKPBYRVSA-N 3, 4 Dihydroxy phenyl alanine Chemical compound OC(=O)[C@H](C)NC1=CC=C(O)C(O)=C1 MBMKGIRTTXAGCM-YFKPBYRVSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 208000001089 Multiple system atrophy Diseases 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- QXWYKJLNLSIPIN-JGVFFNPUSA-N droxidopa Chemical compound OC(=O)[C@@H](N)[C@H](O)C1=CC=C(O)C(O)=C1 QXWYKJLNLSIPIN-JGVFFNPUSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 229940081310 piperonal Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明はラセミまたは光学活性−スレオ−N−
カルボベンゾキシ−3−(3,4−ジヒドロキシ
フエニル)セリンの製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides racemic or optically active -threo-N-
The present invention relates to a method for producing carbobenzoxy-3-(3,4-dihydroxyphenyl)serine.
更に詳しくは一般式〔〕
(式中R1,R2は水素原子またはメチル基を意
味し、少なくとも一方はメチル基を意味する。)
で表わされるラセミまたは光学活性−スレオ−N
−カルボベンゾキシ−3−(3,4−ジヒドロキ
シフエニル)セリン誘導体をルイス酸で処理する
ことにより式〔〕
で表わされるラセミまたは光学活性−スレオ−N
−カルボベンゾキシ−3−(3,4−ジヒドロキ
シフエニル)セリンを製造する方法に関する。 For more details, see the general formula [] (In the formula, R 1 and R 2 mean a hydrogen atom or a methyl group, and at least one of them means a methyl group.) Racemic or optically active -threo-N
-By treating a carbobenzoxy-3-(3,4-dihydroxyphenyl)serine derivative with a Lewis acid, the formula [] racemic or optically active -threo-N represented by
- A method for producing carbobenzoxy-3-(3,4-dihydroxyphenyl)serine.
本発明方法により製造することができるラセミ
または光学活性−スレオ−N−カルボベンゾキシ
−3−(3,4−ジヒドロキシフエニル)セリン
は、医薬品の中間体として有用である。すなわち
パーキンソン病治療剤(特開昭58−52219号公
報)、末梢性起立性低血圧症の治療剤(特開昭56
−104815号公報)あるいは抗うつ剤(特開昭55−
20747号公報)として有用であることが知られて
いるラセミまたは光学活性−スレオ−3−(3,
4−ジヒドロキシフエニル)セリン(以下DOPS
と略称する)を製造する上での中間体として極め
て有用なものである。 Racemic or optically active -threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine that can be produced by the method of the present invention is useful as a pharmaceutical intermediate. Namely, a therapeutic agent for Parkinson's disease (Japanese Patent Application Laid-Open No. 58-52219), a therapeutic agent for peripheral orthostatic hypotension (Japanese Patent Application Laid-Open No. 56-1988)
-104815) or antidepressants (Japanese Patent Application Laid-open No. 104815-
Racemic or optically active threo-3-(3,
4-dihydroxyphenyl)serine (DOPS)
It is extremely useful as an intermediate in the production of
従来、ラセミまたは光学活性−スレオ−N−カ
ルボベンゾキシ−3−(3,4−ジヒドロキシフ
エニル)セリン〔〕の製造方法としては、あら
かじめラセミ−DOPSを製造し、しかる後にカル
ボベンゾキシクロリドと反応させてラセミ−スレ
オ−N−カルボベンゾキシ−3−(3,4−ジヒ
ドロキシフエニル)セリンを製造し、続いてキニ
ンを用い光学分割を行つて光学活性−スレオ−N
−カルボベンゾキシ−3−(3,4−ジヒドロキ
シフエニル)セリンを製造する方法が知られてい
る。(特開昭51−32540号公報)
上記公知法では、一旦ラセミーDOPSを製造し
た後、ラセミ及び光学活性−スレオ−N−カルボ
ベンゾキシ−3−(3,4−ジヒドロキシフエニ
ル)セリンを経て光学活性−DOPSを製造すると
いう、煩雑な操作を必要とする欠点がある。 Conventionally, as a method for producing racemic or optically active -threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine, racemic-DOPS is produced in advance, and then carbobenzoxy chloride and The reaction produces racemic-threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine, followed by optical resolution using quinine to produce optically active -threo-N.
A method for producing -carbobenzoxy-3-(3,4-dihydroxyphenyl)serine is known. (Japanese Unexamined Patent Publication No. 51-32540) In the above-mentioned known method, racemic DOPS is once produced, and then racemic and optically active -threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine is produced. It has the disadvantage of requiring complicated operations to produce optically active DOPS.
更に又、上記方法での原料化合物であるラセミ
ーDOPSの製造においては、工業的にはベラトリ
ルアルデヒド、バニリンあるいはピペロナールの
メチル基あるいはメチレン基を除去することで得
られる式()
で表わされるプロトカテキユアルデヒドのカテコ
ール部分を、除去が容易なエトキシカルボニル基
あるいはベンジル基で保護した一般式〔〕
(式中、R3はエトキシカルボニル基あるいは
ベンジル基を意味する。)
で表わされるベンズアルデヒド誘導体とグリシン
あるいはグリシン誘導体とを縮合するという方法
を経て製造される。〔Chem.Ber.52,1734(1919),
J.Chem.Soc.,658(1947),Chem.Ber.,87,892
(1954),J.Am.Chem.Soc.,76,1322(1954)〕
即ち、ラセミーDOPSを製造するまでに、原料
化合物となるベンズアルデヒド誘導体のカテコー
ル部分の保護基の変更という煩雑な操作を必要と
するという欠点を有している。 Furthermore, in the production of racemic DOPS, which is the raw material compound in the above method, industrially, the formula () obtained by removing the methyl group or methylene group of veratryl aldehyde, vanillin, or piperonal is used. A general formula in which the catechol moiety of protocatechyaldehyde represented by is protected with an easily removable ethoxycarbonyl group or benzyl group [] (In the formula, R 3 means an ethoxycarbonyl group or a benzyl group.) It is produced through a method of condensing a benzaldehyde derivative represented by the following formula with glycine or a glycine derivative. [Chem. Ber. 52 , 1734 (1919),
J.Chem.Soc., 658 (1947), Chem.Ber., 87 , 892
(1954), J.Am.Chem.Soc., 76 , 1322 (1954)] That is, before producing racemic DOPS, a complicated operation of changing the protecting group of the catechol moiety of the benzaldehyde derivative, which is the raw material compound, is necessary. It has the disadvantage that.
一方、メトキシ基あるいはメチレンジオキシ基
をもつ化合物から、メチル基あるいはメチレン基
を除きカテコール基とする方法自体は種々の方法
が知られており、同一分子内にアミノ基やカルボ
キシル基などを有する化合物の例としては、3−
(3,4−メチレンジオキシフエニル)アラニン
またはそのN−アセチル誘導体を、赤リンの存在
下でヨウ化水素酸および無水酢酸で処理して3−
(3,4−ジヒドロキシフエニル)アラニンを得
た例(Chem.Pharm.Bull.,10,693(1962))およ
び2−メチル−3−(3,4−ジメトキシフエニ
ル)アラニンを47.5%臭化水素酸で加熱処理し2
−メチル−3−(3,4−ジヒドロキシフエニル)
アラニンを得た例(J.Am.Chem.Soc.,77,700
(1955))が知られている。しかしこのような反応
条件による方法は、前記一般式〔〕であらわさ
れる化合物の脱メチル基反応には適用できなかつ
た。 On the other hand, various methods are known for removing the methyl group or methylene group from a compound having a methoxy group or methylenedioxy group to form a catechol group. As an example, 3-
(3,4-methylenedioxyphenyl)alanine or its N-acetyl derivative was treated with hydroiodic acid and acetic anhydride in the presence of red phosphorus to produce 3-
Example of obtaining (3,4-dihydroxyphenyl)alanine (Chem.Pharm.Bull., 10 , 693 (1962)) and 2-methyl-3-(3,4-dimethoxyphenyl)alanine with 47.5% odor. Heat treated with hydrochloric acid 2
-Methyl-3-(3,4-dihydroxyphenyl)
Example of obtaining alanine (J.Am.Chem.Soc., 77 , 700
(1955)) is known. However, the method using such reaction conditions could not be applied to the demethylation reaction of the compound represented by the above general formula [].
かかる情況下に、本発明者らは、ラセミまたは
光学活性−DOPSの経済的製造方法を鋭意検討し
た。 Under these circumstances, the present inventors have intensively investigated an economical method for producing racemic or optically active DOPS.
その結果、ベラトリルアラデヒドやバニリンな
どの原料化合物から、カテコール部分の保護基を
変更することなく容易に製造することのできるラ
セミまたは光学活性−スレオ−N−カルボベンゾ
キシ−3−(3,4−ジヒドロキシフエニル)セ
リン誘導体〔〕をルイス酸で処理することによ
り、ラセミまたは光学活性−スレオ−N−カルボ
ベンゾキシ−3−(3,4−ジヒドロキシフエニ
ル)セリン〔〕を製造することができるという
知見を得、本発明を完成した。 As a result, racemic or optically active -threo-N-carbobenzoxy-3-(3, Producing racemic or optically active -threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine [] by treating a 4-dihydroxyphenyl)serine derivative [] with a Lewis acid. The present invention was completed based on the knowledge that this can be done.
すなわち本発明方法により、前記一般式〔〕
であらわされるラセミまたは光学活性−スレオ−
N−カルボベンゾキシ−3−(3,4−ジヒドロ
キシフエニル)セリン誘導体は、メトキシ基の他
にヒドロキシル基、カルバメート基およびカルボ
キシル基を有するにもかかわらず、ルイス酸で緩
和な条件下に処理することによりメチル基が除去
され、前記式〔〕であらわされるラセミまたは
光学活性−スレオ−N−カルボベンゾキシ−3−
(3,4−ジヒドロキシフエニル)セリンを与え
ることを見出した。この反応ではルイス酸の他に
メルカプタン類を加えることが好ましい。 That is, by the method of the present invention, the general formula []
Racemic or optically active -threo-
Although N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine derivatives have hydroxyl, carbamate, and carboxyl groups in addition to methoxy groups, they can be treated with Lewis acids under mild conditions. By doing so, the methyl group is removed and the racemic or optically active -threo-N-carbobenzoxy-3-
It was found that it gives (3,4-dihydroxyphenyl)serine. In this reaction, it is preferable to add mercaptans in addition to the Lewis acid.
本発明の原料化合物〔〕は公知であるか、ま
たは公知の方法もしくは以下に述べる方法に従つ
て容易に製造することができる。例えば米国特許
第3723514号明細書には、ラセミまたは光学活性
−スレオ−N−カルボベンゾキシ−3−(3−メ
トキシ−4−ヒドロキシフエニル)セリンの製造
法が記載されている。また、例えばベラトリルア
ルデヒドとグリシンとの縮合により式〔〕
であらわされるスレオ−3−(3,4−ジメトキ
シフエニル)セリンを得、次いでカルボベンゾキ
シクロリドとのいわゆるシヨツテン・バウマン
(Schotten Baumann)反応を行つてラセミ−ス
レオ−N−カルボベンゾキシ−3−(3,4−ジ
メトキシフエニル)セリンを得ることができる。
さらに必要に応じて光学活性アミンを用いて光学
分割操作を行うことにより、対応する光学活性体
を得ることができる。 The starting compound [ ] of the present invention is known or can be easily produced according to a known method or the method described below. For example, US Pat. No. 3,723,514 describes a process for preparing racemic or optically active -threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine. In addition, for example, by condensation of veratrylaldehyde and glycine, the formula [] Threo-3-(3,4-dimethoxyphenyl)serine represented by is obtained, followed by the so-called Schotten-Baumann reaction with carbobenzoxy chloride to give racemic-threo-N-carbobenzoxy-3. -(3,4-dimethoxyphenyl)serine can be obtained.
Further, if necessary, by performing an optical resolution operation using an optically active amine, a corresponding optically active substance can be obtained.
本発明方法により得られるラセミまたは光学活
性−スレオ−N−カルボベンゾキシ−3−(3,
4−ジヒドロキシフエニル)セリン〔〕から対
応するラセミまたは光学活性−DOPSへの変換
は、例えば溶媒中でパラジウム炭素の存在下に接
触還元を行うことにより実施することができる。 Racemic or optically active -threo-N-carbobenzoxy-3-(3,
Conversion of 4-dihydroxyphenyl)serine to the corresponding racemic or optically active -DOPS can be carried out, for example, by catalytic reduction in a solvent in the presence of palladium on carbon.
上記の一連のDOPS製造方法では従来法に見ら
れるカテコール部分の保護基の変更を必要とせ
ず、経済的なDOPSの製造方法を提供するもので
ある。 The above-mentioned series of methods for producing DOPS does not require changing the protective group of the catechol moiety as seen in conventional methods, and provides an economical method for producing DOPS.
本発明は上記の一連のDOPS製造方法の内、ラ
セミまたは光学活性−スレオ−N−カルボベンゾ
キシ−3−(3,4−ジヒドロキシフエニル)セ
リン誘導体()から対応するラセミまたは光学
活性−スレオ−N−カルボベンゾキシ−3−(3,
4−ジヒドロキシフエニル)セリン()を製造
する方法に関するものである。 Among the above-mentioned series of methods for producing DOPS, the present invention is directed to producing a corresponding racemic or optically active threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine derivative (). -N-carbobenzoxy-3-(3,
The present invention relates to a method for producing 4-dihydroxyphenyl)serine ().
以下に本発明方法を具体的に説明する。 The method of the present invention will be specifically explained below.
ラセミまたは光学活性−スレオ−N−カルボベ
ンゾキシ−3−(3,4−ジヒドロキシフエニル)
セリン誘導体()を適当な溶媒中ルイス酸で処
理すると、対応するラセミまたは光学活性−スレ
オ−N−カルボベンゾキシ−3−(3,4−ジヒ
ドロキシフエニル)セリン()が得られる。 Racemic or optically active -threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)
Treatment of the serine derivative () with a Lewis acid in a suitable solvent provides the corresponding racemic or optically active -threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine ().
ルイス酸としては塩化アルミニウム、臭化アル
ミニウム、塩化第二鉄、塩化第二スズ、塩化ホウ
素、臭化ホウ素等を好ましい例として挙げること
ができる。ルイス酸とジメチルスルフイドとのコ
ンプレツクスをルイス酸として用いても良い。 Preferred examples of Lewis acids include aluminum chloride, aluminum bromide, ferric chloride, stannic chloride, boron chloride, and boron bromide. A complex of Lewis acid and dimethyl sulfide may be used as the Lewis acid.
ルイス酸はスレオ−3−(3,4−ジヒドロキ
シフエニル)セリン誘導体〔〕に対し1〜20倍
モル、好ましくは2〜10倍モル使用する。 The Lewis acid is used in an amount of 1 to 20 times, preferably 2 to 10 times, the amount of the threo-3-(3,4-dihydroxyphenyl)serine derivative.
好ましい結果を得るために、反応液にルイス酸
の他にメチルメルカプタン、エチルメルカプタ
ン、ブチルメルカプタン、オクチールメルカプタ
ン、ドデカニルメルカプタン、オクタデカニルメ
ルカプタン等の炭素数1〜20のメルカプタン類
を、ルイス酸に対し1〜5倍加えることができ
る。 In order to obtain favorable results, in addition to the Lewis acid, mercaptans having 1 to 20 carbon atoms such as methyl mercaptan, ethyl mercaptan, butyl mercaptan, octyl mercaptan, dodecanyl mercaptan, and octadecanyl mercaptan are added to the reaction solution. It can be added 1 to 5 times as much.
反応溶媒としては反応の進行を妨げる溶媒以外
は何を用いても良いが、好ましい溶媒としては、
ジクロロメタン、クロロホルム、ジクロロエタ
ン、クロロベンゼン等のハロゲン化炭化水素系溶
媒、トルエン、ベンゼン等の芳香族炭化水素系溶
媒、酢酸エチル、酢酸ブチル等のエステル系溶
媒、ニトロメタン、ニトロエタン、ニトロベンゼ
ン等のニトロ化炭化水素系溶媒、アセトン、メチ
ルエチルケトン等のケトン系溶媒、ピリジン等、
またはこれらの混合溶媒を挙げることができる。 As the reaction solvent, any solvent may be used other than the solvent that inhibits the progress of the reaction, but preferred solvents are:
Halogenated hydrocarbon solvents such as dichloromethane, chloroform, dichloroethane, and chlorobenzene, aromatic hydrocarbon solvents such as toluene and benzene, ester solvents such as ethyl acetate and butyl acetate, and nitrated hydrocarbons such as nitromethane, nitroethane, and nitrobenzene. solvents, ketone solvents such as acetone and methyl ethyl ketone, pyridine, etc.
Or a mixed solvent thereof can be mentioned.
反応温度は−40〜80℃の範囲で実施することが
できるが、−10〜30℃で実施するのが好ましい。 Although the reaction temperature can be carried out in the range of -40 to 80°C, it is preferably carried out in the range of -10 to 30°C.
反応は10分から4時間の範囲で完結するが反応
時間が長くなつても良い。 The reaction is completed within a range of 10 minutes to 4 hours, but the reaction time may be longer.
本発明方法で使用される原料化合物のうち、例
えば前述のラセミまたは光学活性−スレオ−N−
カルボベンゾキシ−3−(3,4−ジヒドロキシ
フエニル)セリンは次のようにして製造すること
ができる。 Among the raw material compounds used in the method of the present invention, for example, the aforementioned racemic or optically active -threo-N-
Carbobenzoxy-3-(3,4-dihydroxyphenyl)serine can be produced as follows.
即ち、メタノール、エタノール等の溶媒中で、
グリシンとグリシンに対し2倍モルのベラトリル
アルデヒドと2倍モルの水酸化ナトリウム、水酸
化カリウム等の塩基とを反応させた後に酢酸水で
処理することにより、結晶として前記式〔V〕で
あらわされるラセミースレオ−3−(3,4−ジ
メトキシフエニル)セリンを得ることができる。
この時条件によりエリスロ体が多く含まれている
場合には、水から再結晶することによりエリスロ
体を除き、ラセミ−スレオ−3−(3,4−ジメ
トキシフエニル)セリン()を得ることができ
る。続いて水溶液中でPH≒7.5〜10にてカルボベ
ンゾキシクロリドと反応させることによりラセミ
−スレオ−N−カルボベンゾキシ−3−(3,4
−ジメトキシフエニル)セリンが得られる。 That is, in a solvent such as methanol or ethanol,
By reacting glycine with twice the molar amount of veratrylaldehyde and twice the molar amount of a base such as sodium hydroxide or potassium hydroxide relative to glycine, and then treating with aqueous acetic acid, the product is expressed as a crystal by the above formula [V]. racemic threo-3-(3,4-dimethoxyphenyl)serine can be obtained.
If a large amount of erythro isomer is contained depending on the conditions at this time, it is possible to remove the erythro isomer by recrystallizing from water to obtain racemic threo-3-(3,4-dimethoxyphenyl)serine (). can. Subsequently, racemic-threo-N-carbobenzoxy-3-(3,4
-dimethoxyphenyl)serine is obtained.
必要に応じ、このラセミ体に光学活性アミンを
作用させジアステレオマー塩を形成し、D−スレ
オ−N−カルボベンゾキシ−3−(3,4−ジメ
トキシフエニル)セリンのアミン塩とL−スレオ
−N−カルボベンゾキシ−3−(3,4−ジメト
キシフエニル)セリンのアミン塩とに分別した
後、各々の塩に鉱酸を作用させて塩を分解するこ
とにより、光学活性(DおよびL)スレオ−N−
カルボベンゾキシ−3−(3,4−ジメトキシフ
エニル)セリンを得ることができる。 If necessary, this racemate is treated with an optically active amine to form a diastereomer salt, and an amine salt of D-threo-N-carbobenzoxy-3-(3,4-dimethoxyphenyl)serine and L- After separation into amine salt of threo-N-carbobenzoxy-3-(3,4-dimethoxyphenyl)serine, the optically active (D and L) Threo-N-
Carbobenzoxy-3-(3,4-dimethoxyphenyl)serine can be obtained.
次に実施例により本発明方法を説明する。本発
明はもとよりこれに限定されるものではない。 Next, the method of the present invention will be explained by way of examples. The present invention is of course not limited to this.
参考例 1
セラミ−スレオ−3−(3−メトキシ−4−ヒ
ドロキシフエニル)セリン9.0gを、水酸化ナト
リウム2.73gを含む水溶液150mlに5℃以下で加
え、溶解後カルボベンゾキシクロリド7.02gを5
℃以下で滴下した。この間、30%水酸化ナトリウ
ム水溶液を同時に滴下しPH8.5〜9.5になるように
調節した。2時間撹拌を続けた後、濃塩酸を加え
ることによりPH≒2とし酢酸エチルにて抽出し、
有機層を飽和食塩水で洗浄後、硫酸マグネシウム
で乾燥し溶媒を留去した。残渣を酢酸エチルにて
結晶化させることによりラセミ−スレオ−N−カ
ルボベンゾキシ−3−(3−メトキシ−4−ヒド
ロキシフエニル)セリン6.2gを得た。mp147〜
149℃。Reference Example 1 9.0 g of Cerami-threo-3-(3-methoxy-4-hydroxyphenyl)serine was added to 150 ml of an aqueous solution containing 2.73 g of sodium hydroxide at 5°C or below, and after dissolving, 7.02 g of carbobenzoxy chloride was added. 5
It was added dropwise at a temperature below ℃. During this time, a 30% aqueous sodium hydroxide solution was simultaneously added dropwise to adjust the pH to 8.5 to 9.5. After continuing stirring for 2 hours, the pH was adjusted to 2 by adding concentrated hydrochloric acid, and the mixture was extracted with ethyl acetate.
The organic layer was washed with saturated brine, dried over magnesium sulfate, and the solvent was distilled off. The residue was crystallized from ethyl acetate to obtain 6.2 g of racemic-threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine. mp147~
149℃.
実施例 1
上記参考例1で得たラセミ−スレオ−N−カル
ボベンゾキシ−3−(3−メトキシ−4−ヒドロ
キシフエニル)セリン2.0g、エチルメルカプタ
ン3ml、乾燥ジクロロメタン60mlの溶液を5℃以
下に冷却し、無水臭化アルミニウム6.0gを加え
た。室温で15時間撹拌後エチルメルカプタン3ml
および無水臭化アルミニウム6.0gを追加して室
温で72時間撹拌した。さらにエチルメルカプタン
3mlおよび無水臭化アルミニウム6.0gを追加し
て15時間撹拌した。この反応混合物を5%シユウ
酸水200ml中に20℃以下で滴下した後、酢酸エチ
ル100mlで3回抽出した。酢酸エチル層を飽和食
塩水100mlで3回洗浄し、無水芒硝で乾燥後酢酸
エチルを留去することによりラセミ−スレオ−N
−カルボベンゾキシ−3−(3,4−ジヒドロキ
シフエニル)セリン0.04gを得た。Example 1 A solution of 2.0 g of racemic-threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine obtained in Reference Example 1, 3 ml of ethyl mercaptan, and 60 ml of dry dichloromethane was heated below 5°C. 6.0 g of anhydrous aluminum bromide was added. After stirring at room temperature for 15 hours, add 3 ml of ethyl mercaptan.
Then, 6.0 g of anhydrous aluminum bromide was added and stirred at room temperature for 72 hours. Furthermore, 3 ml of ethyl mercaptan and 6.0 g of anhydrous aluminum bromide were added and stirred for 15 hours. This reaction mixture was added dropwise to 200 ml of 5% oxalic acid water at 20°C or lower, and then extracted three times with 100 ml of ethyl acetate. The ethyl acetate layer was washed three times with 100 ml of saturated brine, dried over anhydrous sodium sulfate, and the ethyl acetate was distilled off to give racemic threo-N
-Carbobenzoxy-3-(3,4-dihydroxyphenyl)serine 0.04 g was obtained.
mp 147℃(分解)
参考例 2
上記実施例1で得たラセミ−スレオ−N−カル
ボベンゾキシ−3−(3,4−ジヒドロキシフエ
ニル)セリン0.035gをメタノール0.5mlに溶解
し、10%パラジウム炭素(50%含水)0.005gを
加え常圧にて接触還元を行つた。水素をもはや吸
収しなくなつてから濃塩酸0.015gを加えて撹拌
後不溶物を去し、母液をジエチルアミンにてPH
≒5.5とした。析出晶を取してラセミ−スレオ
−3−(3,4−ジヒドロキシフエニル)セリン
0.019gを得た。mp 147℃ (decomposition) Reference Example 2 0.035 g of racemic-threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine obtained in Example 1 above was dissolved in 0.5 ml of methanol, and 10% 0.005 g of palladium on carbon (50% water content) was added and catalytic reduction was carried out at normal pressure. After no longer absorbing hydrogen, add 0.015 g of concentrated hydrochloric acid, stir, remove insoluble matter, and PH the mother liquor with diethylamine.
It was set as ≒5.5. Remove the precipitated crystals and prepare racemic threo-3-(3,4-dihydroxyphenyl)serine.
0.019g was obtained.
mp 222〜224℃
参考例 3
参考例1で得たラセミ−スレオ−N−カルボベ
ンゾキシ−3−(3−メトキシ−4−ヒドロキシ
フエニル)セリン4.0gを10%含水エタノール120
mlに溶解させ、キニン・3水和物4.36gを加え60
℃に加熱して溶解させた。そのまま8日間放置
後、析出した結晶を取してL−スレオ−N−カ
ルボベンゾキシ−3−(3−メトキシ−4−ヒド
ロキシフエニル)セリン・キニン塩2.6gを得た。mp 222-224℃ Reference Example 3 4.0 g of racemic-threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine obtained in Reference Example 1 was added to 120 g of 10% aqueous ethanol.
ml and add 4.36g of quinine trihydrate to 60ml.
It was heated to ℃ to dissolve it. After standing for 8 days, the precipitated crystals were collected to obtain 2.6 g of L-threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine quinine salt.
mp140〜142℃,〔α〕20 D−92゜(C=1、エタノー
ル)
この塩をN−塩酸100mlに加え酢酸エチル200ml
で2回抽出し、無水芒硝で乾燥後酢酸エチルを留
去することによりL−スレオ−N−カルボベンゾ
キシ−3−(3−メトキシ−4−ヒドロキシフエ
ニル)セリン1.25gを得た。mp143〜145℃,
〔α〕20 D−21.0゜(C=1、メタノール)
実施例 2
参考例3で得たL−スレオ−N−カルボベンゾ
キシ−3−(3−メトキシ−4−ヒドロキシフエ
ニル)セリン1.1g、エチルメルカプタン1.65ml、
乾燥ジクロロメタン33mlの溶液を5℃以下に冷却
し、無水臭化アルミニウム3.3gを加えた。室温
で24時間撹拌した後エチルメルカプタン1.65mlお
よび無水臭化アルミニウム3.3gを追加して室温
にて70時間撹拌した。さらにエチルメルカプタン
1.65mlおよび無水臭化アルミニウム3.3gを追加
して12時間撹拌した。反応混合物を5%シユウ酸
水100ml中に20℃以下で滴下し、酢酸エチル50ml
で3回抽出した。酢酸エチル層は合わして飽和食
塩水50mlで3回洗浄した。この酢酸エチル層は無
水芒硝で乾燥後溶媒を留去すると油状物としてL
−スレオ−N−カルボベンゾキシ−3−(3,4
−ジヒドロキシフエニル)セリン0.025gを得た。
〔α〕20 D−26.8°(C=1、メタノール)
参考例 4
実施例2で得たL−スレオ−N−カルボベンゾ
キシ−3−(3,4−ジヒドロキシフエニル)セ
リン0.025gをメタノール0.5mlに溶解し、10%パ
ラジウム炭素(50%含水)0.005gを加え常圧に
て接触還元を行つた。水素をもはや吸収しなくな
つてから濃塩酸0.011gを加えて撹拌後不溶物を
去し、母液をジエチルアミンにてPH≒5.5とし
た。析出晶を取してL−スレオ−3−(3,4
−ジヒドロキシフエニル)セリン0.013gを得た。
mp223〜225℃,〔α〕20 D−38.0°(C=1、N−塩
酸)
参考例 5
ラセミ−スレオ−3−(3,4−ジメトキシフ
エニル)セリン・塩酸塩3.0gを水酸化ナトリウ
ム0.86gを含む水溶液50mlに5℃以下で加え、溶
解後カルボベンゾキシクロリド2.2gを5℃以下
で滴下した。この間、30%水酸化ナトリウム水溶
液を同時に滴下し、PH8.5〜9.5になるように調節
した。2時間後、濃塩酸を加えることによりPH≒
2とし酢酸エチルにて抽出し、有機層を飽和食塩
水で洗浄後、硫酸マグネシウムで乾燥し溶媒を留
去した。残渣を酢酸エチルにて結晶化し、結晶を
取することによりラセミースレオ−N−カルボ
ベンゾキシ−3−(3,4−ジメトキシフエニル)
セリン1.37gを得た。mp121〜125℃
実施例 3
参考例5で得たラセミ−スレオ−N−カルボベ
ンゾキシ−3−(3,4−ジメトキシフエニル)
セリン1.0g、エチルメルカプタン1.5ml、乾燥ジ
クロロメタン18mlの溶液を5℃以下に冷却し、無
水塩化アルミニウム1.4gを加え室温で15時間撹
拌後、エチルメルカプタン1.5mlおよび無水臭化
アルミニウム2.8gを追加した。室温で72時間撹
拌した後、さらにエチルメルカプタン1.5mlおよ
び無水臭化アルミニウム2.8gを追加して15時間
撹拌した。反応混合物を5%シユウ酸水100ml中
に20℃以下で滴下し、酢酸エチル50mlで3回抽出
した。酢酸エチル層を合わせて飽和食塩水50mlで
3回洗浄し、無水芒硝で乾燥後溶媒を留去するこ
とによりラセミ−スレオ−N−カルボベンゾキシ
−3−(3,4−ジヒドロキシフエニル)セリン
0.04gを得た。mp148℃(分解)
参考例 6
実施例3で得たラセミ−スレオ−N−カルボベ
ンゾキシ−3−(3,4−ジヒドロキシフエニル)
セリン0.035gをメタノール0.5mlに溶解し、10%
パラジウム炭素(50%含水)0.005gを加え常圧
にて接触還元を行つた。水素をもはや吸収しなく
なつてから濃塩酸0.015gを加えて撹拌後不溶物
を去し母液をジエチルアミンにてPH≒5.5とし
た。析出晶を取してラセミ−スレオ−3−(3,
4−ジヒドロキシフエニル)セリン0.02gを得
た。mp222〜225℃。mp140-142℃, [α] 20 D -92゜ (C=1, ethanol) Add this salt to 100ml of N-hydrochloric acid and 200ml of ethyl acetate.
After drying with anhydrous sodium sulfate, ethyl acetate was distilled off to obtain 1.25 g of L-threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine. mp143~145℃,
[α] 20 D -21.0° (C=1, methanol) Example 2 1.1 g of L-threo-N-carbobenzoxy-3-(3-methoxy-4-hydroxyphenyl)serine obtained in Reference Example 3 , ethyl mercaptan 1.65ml,
A solution of 33 ml of dry dichloromethane was cooled to below 5°C and 3.3 g of anhydrous aluminum bromide was added. After stirring at room temperature for 24 hours, 1.65 ml of ethyl mercaptan and 3.3 g of anhydrous aluminum bromide were added, and the mixture was stirred at room temperature for 70 hours. Furthermore, ethyl mercaptan
1.65 ml and 3.3 g of anhydrous aluminum bromide were added and stirred for 12 hours. The reaction mixture was added dropwise to 100 ml of 5% oxalic acid water at below 20°C, and 50 ml of ethyl acetate was added.
Extracted three times. The ethyl acetate layers were combined and washed three times with 50 ml of saturated brine. This ethyl acetate layer was dried with anhydrous sodium sulfate and the solvent was distilled off, leaving L as an oil.
-threo-N-carbobenzoxy-3-(3,4
-dihydroxyphenyl)serine 0.025 g was obtained.
[α] 20 D -26.8° (C=1, methanol) Reference example 4 0.025 g of L-threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine obtained in Example 2 was added to methanol. The solution was dissolved in 0.5 ml, 0.005 g of 10% palladium on carbon (50% water content) was added, and catalytic reduction was performed at normal pressure. After hydrogen was no longer absorbed, 0.011 g of concentrated hydrochloric acid was added, and after stirring, insoluble matter was removed, and the mother liquor was adjusted to pH≈5.5 with diethylamine. The precipitated crystals were collected and L-threo-3-(3,4
-dihydroxyphenyl)serine 0.013 g was obtained.
mp223~225℃, [α] 20 D -38.0° (C=1, N-hydrochloric acid) Reference example 5 Add 3.0 g of racemic threo-3-(3,4-dimethoxyphenyl) serine hydrochloride to sodium hydroxide. It was added to 50 ml of an aqueous solution containing 0.86 g at below 5°C, and after dissolving, 2.2 g of carbobenzoxy chloride was added dropwise at below 5°C. During this time, a 30% aqueous sodium hydroxide solution was simultaneously added dropwise to adjust the pH to 8.5 to 9.5. After 2 hours, pH≒ by adding concentrated hydrochloric acid.
2 and extracted with ethyl acetate, and the organic layer was washed with saturated brine, dried over magnesium sulfate, and the solvent was distilled off. The residue was crystallized from ethyl acetate and the crystals were collected to give racemic threo-N-carbobenzoxy-3-(3,4-dimethoxyphenyl).
1.37 g of serine was obtained. mp121-125℃ Example 3 Racemic-threo-N-carbobenzoxy-3-(3,4-dimethoxyphenyl) obtained in Reference Example 5
A solution of 1.0 g of serine, 1.5 ml of ethyl mercaptan, and 18 ml of dry dichloromethane was cooled to below 5°C, 1.4 g of anhydrous aluminum chloride was added, and after stirring at room temperature for 15 hours, 1.5 ml of ethyl mercaptan and 2.8 g of anhydrous aluminum bromide were added. . After stirring at room temperature for 72 hours, 1.5 ml of ethyl mercaptan and 2.8 g of anhydrous aluminum bromide were further added, and the mixture was stirred for 15 hours. The reaction mixture was added dropwise to 100 ml of 5% oxalic acid water at below 20°C, and extracted three times with 50 ml of ethyl acetate. The ethyl acetate layers were combined, washed three times with 50 ml of saturated brine, dried over anhydrous sodium sulfate, and the solvent was distilled off to obtain racemic-threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl)serine.
0.04g was obtained. mp148℃ (decomposition) Reference example 6 Racemic-threo-N-carbobenzoxy-3-(3,4-dihydroxyphenyl) obtained in Example 3
Dissolve 0.035g of serine in 0.5ml of methanol, 10%
0.005 g of palladium on carbon (50% water content) was added and catalytic reduction was carried out at normal pressure. After hydrogen was no longer absorbed, 0.015 g of concentrated hydrochloric acid was added, and after stirring, insoluble matter was removed, and the mother liquor was adjusted to pH≈5.5 with diethylamine. The precipitated crystals were collected and racemic threo-3-(3,
0.02 g of 4-dihydroxyphenyl)serine was obtained. mp222~225℃.
Claims (1)
−カルボベンゾキシ−3−(3,4−ジヒドロキ
シフエニル)セリンを製造するにあたり、 式 (式中R1,R2は水素原子またはメチル基を意
味し、少なくとも一方はメチル基を意味する。) で表わされるラセミまたは光学活性−スレオ−N
−カルボベンゾキシ−3−(3,4−ジヒドロキ
シフエニル)セリン誘導体をルイス酸で処理する
ことを特徴とするラセミまたは光学活性−スレオ
−N−カルボベンゾキシ−3−(3,4−ジヒド
ロキシフエニル)セリンの製造方法。[Claims] 1 formula racemic or optically active -threo-N represented by
- In producing carbobenzoxy-3-(3,4-dihydroxyphenyl)serine, the formula (In the formula, R 1 and R 2 mean a hydrogen atom or a methyl group, and at least one of them means a methyl group.) Racemic or optically active -threo-N
- Racemic or optically active carbobenzoxy-3-(3,4-dihydroxyphenyl)serine derivative characterized by treatment with a Lewis acid -Threo-N-carbobenzoxy-3-(3,4-dihydroxy Method for producing phenyl)serine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9754483A JPS59222465A (en) | 1983-05-31 | 1983-05-31 | Preparation of threo-n-carbobenzoxy-3-(3,4- dihydroxyphenyl)serine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9754483A JPS59222465A (en) | 1983-05-31 | 1983-05-31 | Preparation of threo-n-carbobenzoxy-3-(3,4- dihydroxyphenyl)serine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59222465A JPS59222465A (en) | 1984-12-14 |
JPH0316946B2 true JPH0316946B2 (en) | 1991-03-06 |
Family
ID=14195180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9754483A Granted JPS59222465A (en) | 1983-05-31 | 1983-05-31 | Preparation of threo-n-carbobenzoxy-3-(3,4- dihydroxyphenyl)serine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59222465A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5124950B2 (en) * | 2006-01-31 | 2013-01-23 | 大日本印刷株式会社 | Method for producing optically active serine derivative |
-
1983
- 1983-05-31 JP JP9754483A patent/JPS59222465A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59222465A (en) | 1984-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4562263A (en) | Process for producing 3-(3,4-dihydroxyphenyl) serine | |
US4480109A (en) | Process for producing threo-3-(3,4-dihydroxyphenyl)serine | |
JPH0567634B2 (en) | ||
JP2931986B2 (en) | Aralkylamine derivatives | |
JPH0316946B2 (en) | ||
US4399284A (en) | Process for the optical resolution of mixtures of D- and L-2-(6-methoxy-2-naphthyl)-propionic acids | |
JP3088777B2 (en) | Novel optical resolving agent and method for producing optically active amine using the same | |
JPH0520425B2 (en) | ||
JPH02243663A (en) | Method for synthesizing optically active amino acid | |
EP0084928B1 (en) | Process for producing threo-3-(3,4-dihydroxyphenyl)serine | |
JP2830364B2 (en) | Method for producing optically active 1-benzyl-3-hydroxypyrrolidine | |
JPH07330732A (en) | Optically active 3-amino-1-benzylpiperidine derivative | |
JP2861274B2 (en) | Amino ketone derivatives | |
JPH0315624B2 (en) | ||
JPH02306942A (en) | Production of optically active phenylethylamine derivative | |
JPH0149139B2 (en) | ||
JPH0778052B2 (en) | Optical resolution method of DL-pantolactone | |
JP3304419B2 (en) | Method for producing optically active 1- (4-halogenophenyl) ethylamine | |
JPH0549659B2 (en) | ||
JPH10237013A (en) | Production of optically active 2-benzylsuccinic acid | |
SU1627081A3 (en) | Process for preparation of hydroxydipraphenon and its pharmacologic available salts | |
JP3084577B2 (en) | Method for producing optically active atrolactic acid and intermediate for production | |
JPH0160002B2 (en) | ||
JP2863002B2 (en) | Optical resolution of optically active 2- (alkyl-substituted phenyl) propionic acid derivatives and (±) -1-methyl-3-phenylpropylamine | |
JP2003238506A (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE beta-PHENYLALANINE DERIVATIVE |